# A Study of Topical Steroids as Preemptive Therapy for EGFR Inhibitor-Induced Papulopustular Eruption

> **NCT03115567** · PHASE2 · TERMINATED · sponsor: **Northwestern University** · enrollment: 14 (actual)

## Conditions studied

- Acneiform Rash
- Papulopustular Eruption

## Interventions

- **DRUG:** Triamcinolone

## Key facts

- **NCT ID:** NCT03115567
- **Lead sponsor:** Northwestern University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2017-02-16
- **Primary completion:** 2020-04-24
- **Final completion:** 2022-09-02
- **Target enrollment:** 14 (ACTUAL)
- **Why stopped:** Low enrollment accrual
- **Last updated:** 2023-05-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03115567

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03115567, "A Study of Topical Steroids as Preemptive Therapy for EGFR Inhibitor-Induced Papulopustular Eruption". Retrieved via AI Analytics 2026-05-23 from https://api.ai-analytics.org/clinical/NCT03115567. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*